Sagimet Biosciences Inc
NASDAQ:SGMT

Watchlist Manager
Sagimet Biosciences Inc Logo
Sagimet Biosciences Inc
NASDAQ:SGMT
Watchlist
Price: 8.89 USD -4.1% Market Closed
Market Cap: 286.3m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+258%
Revenue
Forecast
N/A
Operating Income
Forecast
-44%
Net Income
Forecast
-28%

Wall Street
Price Targets

SGMT Price Targets Summary
Sagimet Biosciences Inc

Wall Street analysts forecast SGMT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SGMT is 31.79 USD with a low forecast of 11.11 USD and a high forecast of 70.35 USD.

SGMT Lowest Forecast
Wall Street Target
11.11 USD
25% Upside
SGMT Average Forecast
Wall Street Target
31.79 USD
258% Upside
SGMT Highest Forecast
Wall Street Target
70.35 USD
691% Upside
Lowest
Price Target
11.11 USD
25% Upside
Average
Price Target
31.79 USD
258% Upside
Highest
Price Target
70.35 USD
691% Upside
Sagimet Biosciences Inc Competitors:
Price Targets
LGND
Ligand Pharmaceuticals Inc
11% Upside
MDXG
MiMedx Group Inc
88% Upside
MRNA
Moderna Inc
61% Upside
MCRB
Seres Therapeutics Inc
236% Upside
LGND
Ligand Pharmaceuticals Inc
11% Upside
MDXG
MiMedx Group Inc
88% Upside
MRNA
Moderna Inc
61% Upside
MCRB
Seres Therapeutics Inc
236% Upside
TH
Theratechnologies Inc
30% Upside
A
ACLX
Arcellx Inc
59% Upside
SPRO
Spero Therapeutics Inc
134% Upside
PRQR
ProQR Therapeutics NV
329% Upside

Revenue
Forecast

Revenue Estimate
Sagimet Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sagimet Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sagimet Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
SGMT intrinsic value, competitors valuation, and company profile.
DCF Valuation
SGMT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SGMT stock valuation using valuation multiples.
Wall Street Estimates
SGMT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SGMT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SGMT's stock price target?
Price Target
31.79 USD

According to Wall Street analysts, the average 1-year price target for SGMT is 31.79 USD with a low forecast of 11.11 USD and a high forecast of 70.35 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 271,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.